American Healthcare REIT (NYSE:AHR) Releases FY 2024 Earnings Guidance

American Healthcare REIT (NYSE:AHR) issued an update on its FY 2024 earnings guidance on Thursday morning. The company provided earnings per share guidance of 1.180-1.240 for the period, compared to the consensus earnings per share estimate of 1.220. The company issued revenue guidance of -.

American Healthcare REIT Trading Up 1.0 %

Shares of AHR traded up $0.14 during midday trading on Thursday, reaching $14.18. 890,369 shares of the stock were exchanged, compared to its average volume of 874,312. American Healthcare REIT has a twelve month low of $12.63 and a twelve month high of $14.56.

American Healthcare REIT Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Friday, April 19th. Stockholders of record on Thursday, March 28th will be paid a dividend of $0.25 per share. This represents a $1.00 annualized dividend and a dividend yield of 7.05%. The ex-dividend date is Wednesday, March 27th.

Wall Street Analysts Forecast Growth

Several equities research analysts have recently issued reports on the company. Bank of America assumed coverage on American Healthcare REIT in a report on Monday, March 4th. They set a buy rating and a $15.00 price objective on the stock. Truist Financial started coverage on American Healthcare REIT in a report on Monday, March 4th. They set a buy rating and a $17.00 price objective on the stock. Royal Bank of Canada started coverage on American Healthcare REIT in a research report on Monday, March 4th. They issued an outperform rating and a $15.00 target price on the stock. Barclays started coverage on American Healthcare REIT in a research report on Thursday, March 14th. They issued an overweight rating and a $18.00 target price on the stock. Finally, Morgan Stanley started coverage on American Healthcare REIT in a research report on Monday, March 4th. They issued an overweight rating and a $17.00 target price on the stock. One investment analyst has rated the stock with a hold rating and six have assigned a buy rating to the company. According to data from MarketBeat, the stock presently has a consensus rating of Moderate Buy and an average target price of $16.00.

Insider Buying and Selling at American Healthcare REIT

In related news, Director Mathieu B. Streiff bought 83,333 shares of the firm’s stock in a transaction on Friday, February 9th. The stock was bought at an average cost of $12.00 per share, for a total transaction of $999,996.00. Following the completion of the purchase, the director now directly owns 90,740 shares in the company, valued at approximately $1,088,880. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink.

About American Healthcare REIT

Formed by the successful merger of Griffin-American Healthcare REIT III and Griffin-American Healthcare REIT IV, as well as the acquisition of the business and operations of American Healthcare Investors, American Healthcare REIT is one of the larger healthcare-focused real estate investment trusts globally with assets totaling approximately $4.2 billion in gross investment value.